The company is showcasing new development solutions and advanced digital technologies including its new OSD Express and Steriles Express solutions for drug development.
|Articles|October 7, 2011
Pinewood Healthcare
With over 30 years manufacturing healthcare products in Ireland, Pinewood Healthcare is one of the largest generic companies with a workforce of over 340 people.
Advertisement
With over 30 years manufacturing healthcare products in Ireland, Pinewood Healthcare is one of the largest generic companies with a workforce of over 340 people. We are a widely diversified pharmaceutical group and market our products in over 30 countries across the globe. Pinewood Healthcare also markets and distributes branded generics to retail pharmacies and hospitals throughout Ireland.Pinewood Healthcare can offer contract manufacturing and packaging in the following areas: Oral Liquid and Suspensions, Glass, HDPE, Pet, Sachets, Cream and Ointments, Tubes and tubs (plastic and Aluminium), Non- Penicillin Powders, Glass, HDPE, Sachets.
Our manufacturing site in Tipperary has internationally recognised quality standards- ISO9001 and the CE mark which reflects the high standards maintained in Pinewood, at all times manufacturing in a GMP environment. Continuous investment on a purpose built site has created one of the most sophisticated and state of the art factories of its type in Europe.
Our promise is to offer quality products, competitively priced, delivered on time and backed by individual customer service, technical advice and marketing support.
Advertisement
Related to this article
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Shadow AI and vendor data retention put GMP records and trade secrets at risk. AI Pulse Check panelists outline what pharma AI policies require.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Advertisement
Advertisement